The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GeoVax Labs Inc. shares valued at $820 were purchased by Sharkey John W. on Jul 01. At $0.82 per share, Sharkey John W. acquired 1,000 shares. The insider’s holdings grew to 2,860 shares worth approximately $2860.0 following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, McKee Kelly T. Jr. purchased 4,464 shares, netting a total of over 5,000 in proceeds. Following the buying of shares at $1.12 each, the insider now holds 19,185 shares.
Before that, CHASE RANDAL D had added 10,000 shares to its account. In a trade valued at $12,100, the Director bought GeoVax Labs Inc. shares for $1.21 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $26613.0.
As published in their initiating research note from Maxim Group on November 19, 2020, GeoVax Labs Inc. [GOVX] has been a Buy and the price target has been revised to $8. This represents a 87.5% premium over Thursday’s closing price.
Analyzing GOVX’s Price Performance
On Thursday, GeoVax Labs Inc. [NASDAQ: GOVX] plunged -8.56% to $1.00. The stock’s lowest price that day was $0.9701, but it reached a high of $1.10 in the same session. During the last five days, there has been a drop of approximately -27.78%. Over the course of the year, GeoVax Labs Inc. shares have dropped approximately -72.47%. Shares of the company reached a 52-week high of $4.3000 on 08/01/22 and a 52-week low of $0.5495 on 05/12/22. A 50-day SMA is recorded $1.7078, while a 200-day SMA reached $1.8231. Nevertheless, trading volume fell to 1.83 million shares from 1.63 million shares the previous day.
Support And Resistance Levels for GeoVax Labs Inc. (GOVX)
According to the 24-hour chart, there is a support level at 0.9445, which, if violated, would cause prices to drop to 0.8924. In the upper region, resistance lies at 1.0744. The next price resistance is at 1.1522. RSI (Relative Strength Index) is 37.67 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2021, which suggests the price will decrease in the coming days. Percent R is at 96.98%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is GeoVax Labs Inc. subject to short interest?
Stocks of GeoVax Labs Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.24 million shares to 0.1 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 0.34 million shares. A decline of -238.57% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.05 of the overall float, the days-to-cover ratio (short ratio) decline to 0.05.
Which companies own the most shares of GeoVax Labs Inc. (GOVX)?
According to Armistice Capital LLC filings, the company currently owns 1,358,439 shares, which is about 5.49% of the total GOVX shares outstanding. The investor’s shares have appreciated by 923,289 from its previous 13-F filing of 435150.0 shares. A total of 19,409 shares of GeoVax Labs Inc. were bought by Virtu Financial BD LLC during the quarter, and 55,550 were bought by Tower Research Capital LLC. In its current portfolio, Geode Capital Management LLC holds 54,842 shares valued at $65262.0.
In terms of GeoVax Labs Inc. share price expectations, FactSet research, analysts set an average price target of $6.00 in the next 12 months, up nearly 450.46% from the previous closing price of $1.09. Analysts anticipate GeoVax Labs Inc. stock to reach $6.00 by 2022, with the lowest price target being $6.00. In spite of this, 1 analysts ranked GeoVax Labs Inc. stock as a Buy at the end of 2022.